JNJ-10198409 blocks the activity of platelet-derived growth factor receptors (PDGFR), which play a crucial role in cell growth, angiogenesis, and tissue.
Molecular Weight
325.3434
Molecular Formula
C18H16FN3O2
Form
Lyophilized powder
Purity
≥98%
Identity
Confirmed by NMR/HPLC/MS.
Applications
JNJ-10198409 serves as a PDGFR inhibitor, enabling research into interrupting pathological signaling in cancer.
CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.
